TrialScope to Speak at CBI’s 7th Annual Publication and Clinical Trial Transparency Event

June 20, 2018 Zurab Akirtava

Company’s Chief Strategy Officer to present on how sponsors can take control of their clinical trial disclosure and boost transparency

Jersey City, NJ – June 20, 2018 – TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that its Chief Strategy Officer, Thomas Wicks, will deliver a presentation titled “Develop Your Disclosure Dashboard — A Quick Guide to Global Transparency” at CBI’s 7th Annual Publication and Clinical Trial Transparency Conference on June 20 at 10:15 am CEST. The conference, which is also sponsored by TrialScope, will take place in Amsterdam, Netherlands, from June 20-21, 2018.

As regulations continue to evolve globally, Wicks will provide sponsors with insight into how they can adapt their own compliance and transparency initiatives by answering basic questions about disclosure for any given clinical trial:

  • What level of detail was disclosed?
  • What data was disclosed?
  • When was it disclosed?
  • Was the data disclosed in accordance to law?

In addition, Wicks will discuss specific global regulations – including those from the U.S. and EU – as well as provide a review of non-compliance issues and a preview of what’s next in global clinical trial compliance.

“It can be difficult for clinical trial sponsors to keep up with the ever-changing regulations around the world – especially as there are now more than 40 trial registries and over 90 countries with clinical transparency requirements,” said Wicks. “With this session, I hope to provide sponsors with actionable insights that will enable them to take control of their clinical trial compliance initiatives.”

For more information on CBI’s 7th Annual Publication and Clinical Trial Transparency Conference, and the full agenda, visit: http://www.cbinet.com/conference/pc18204

About TrialScope
TrialScope simplifies the complexities of clinical trial transparency. TrialScope’s award-winning, proven solutions have been implemented successfully and rigorously tested in the most complex environments and are managing disclosures for sponsors that are responsible for over 40 percent of industry sponsored clinical trials posted on clinicaltrials.gov. The Company’s market-driven solutions and expertise enable sponsors to improve performance, mitigate compliance risk, and ultimately optimize efficiencies with clinical content lifecycle management tools, expertise and processes. TrialScope technologies are offered via a validation-ready SaaS platform hosted in a private cloud. For more information, visit www.trialscope.com.

The post TrialScope to Speak at CBI’s 7th Annual Publication and Clinical Trial Transparency Conference on Global Compliance appeared first on TrialScope.

Previous Article
Top Global Pharma Company Selects TrialScope for Clinical Trial Disclosure, Transparency Support
Top Global Pharma Company Selects TrialScope for Clinical Trial Disclosure, Transparency Support

TrialScope was selected by GlaxoSmithKline to facilitate clinical trial disclosure and transparency, which ...

Next Article
TrialScope Appoints Francine Lane as Vice President of Global Transparency
TrialScope Appoints Francine Lane as Vice President of Global Transparency

TrialScope, the global leader in clinical trial transparency and compliance solutions, announced new findin...